Molina Healthcare, Inc. MOH
We take great care to ensure that the data presented and summarized in this overview for MOLINA HEALTHCARE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MOH
View all-
Vanguard Group Inc Valley Forge, PA6.66MShares$1.94 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY5.19MShares$1.51 Billion0.04% of portfolio
-
Capital World Investors Los Angeles, CA5.13MShares$1.49 Billion0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$1.15 Billion0.16% of portfolio
-
Capital Research Global Investors Los Angeles, CA3.49MShares$1.02 Billion0.26% of portfolio
-
State Street Corp Boston, MA2.61MShares$760 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA2.45MShares$713 Million0.15% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.01MShares$584 Million0.42% of portfolio
-
Capital International Investors Los Angeles, CA1.71MShares$499 Million0.12% of portfolio
-
Geode Capital Management, LLC Boston, MA1.4MShares$408 Million0.04% of portfolio
Latest Institutional Activity in MOH
Top Purchases
Top Sells
About MOH
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Insider Transactions at MOH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 18
2024
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
136
-1.16%
|
$39,712
$292.72 P/Share
|
Oct 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+5.82%
|
$54,901
$341.91 P/Share
|
Oct 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.56%
|
$54,901
$341.91 P/Share
|
Oct 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+3.84%
|
$54,901
$341.91 P/Share
|
Oct 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
161
+2.31%
|
$54,901
$341.91 P/Share
|
Oct 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+1.36%
|
$54,901
$341.91 P/Share
|
Oct 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
161
+0.88%
|
$54,901
$341.91 P/Share
|
Oct 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
161
+0.92%
|
$54,901
$341.91 P/Share
|
Oct 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+1.04%
|
$54,901
$341.91 P/Share
|
Aug 15
2024
|
Maurice Hebert Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
393
-3.98%
|
$135,978
$346.52 P/Share
|
Jul 30
2024
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
1,000
-5.26%
|
$339,000
$339.21 P/Share
|
Jul 29
2024
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,340
-7.47%
|
$1,788,900
$335.0 P/Share
|
Jul 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+7.15%
|
$54,896
$292.16 P/Share
|
Jul 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
188
+1.09%
|
$54,896
$292.16 P/Share
|
Jul 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+3.05%
|
$54,896
$292.16 P/Share
|
Jul 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+4.63%
|
$54,896
$292.16 P/Share
|
Jul 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
188
+0.98%
|
$54,896
$292.16 P/Share
|
Jul 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+1.22%
|
$54,896
$292.16 P/Share
|
Jul 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+1.6%
|
$54,896
$292.16 P/Share
|
Jul 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
188
+2.75%
|
$54,896
$292.16 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 148K shares |
---|
Payment of exercise price or tax liability | 85.2K shares |
---|---|
Open market or private sale | 36.9K shares |
Bona fide gift | 5.7K shares |